InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
-6.4%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Sinclair Andrew, 董事. Insider active across 3 companies, notably Adicet Bio, Inc.. In total, 10 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €12.4m. Activity tracked since 8 December 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sinclair Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
5,900 股0Common StockSEC:0000950170-25-086135:0
3,991 股0Common StockSEC:0001415889-25-016360:0
6,500 股0Common StockSEC:0001415889-24-016311:0
5,900 股0Common StockSEC:0000950170-24-070575:0
5,900 股0Common StockSEC:0001209191-23-033955:0
1,314,127 股@ US$55.0091.0% 占其流量Common Stock, $0.001 par valueSEC:0001493152-22-018397:0
7,720,000 股Common StockSEC:0000905718-22-000521:0
标准退出：2022年6月27日 (T+90)
287,471 股@ US$13.204.7% 占其流量Common Stock, $0.001 par valueSEC:0000905718-22-000178:0
500,000 股@ US$14.007.69% mcap25.0% 占其流量Common StockSEC:0000905718-21-001591:0
标准退出：2022年3月8日 (T+90)
500,000 股@ US$14.00100.0% 占其流量Common StockSEC:0000905718-21-001587:0
标准退出：2022年3月8日 (T+90)
10 条申报中的 10 条
About Sinclair Andrew
Sinclair Andrew is Administrateur and a declarant, and is listed as a director at Adicet Bio, Inc., Soleno Therapeutics INC, and Sierra Oncology, Inc. He has filed 10 forms in total, and across the 10 recent filings available, the buy and sell amounts are 12415200 and 68981875 respectively, with activity from 2021-12-10 to 2025-06-13.
